Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE: DNA · Real-Time Price · USD

Compare

8.27

-0.52 (-5.92%)

At close: Feb 4, 2026, 4:00 PM EST

8.43

+0.16 (1.93%)

After-hours: Feb 4, 2026, 7:56 PM EST

Ginkgo Bioworks Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-339.55	-547.03	-892.87	-2,105	-1,830	-126.61
Depreciation & Amortization	60.28	63.02	70.51	42.55	29.08	13.86
Loss (Gain) From Sale of Assets	0.84	7.86	43.34	-28.8	-	-
Asset Writedown & Restructuring Costs	5.8	78.27	130.59	1.16	-	-
Loss (Gain) From Sale of Investments	10.32	28.83	54.83	53.34	11.54	3.73
Loss (Gain) on Equity Investments	-	-	2.64	43.76	77.28	0.4
Stock-Based Compensation	81.08	112.34	229.88	1,931	1,606	0.48
Other Operating Activities	33.04	26.79	35.75	-152.92	-86.16	-1.18
Change in Accounts Receivable	1.72	-4.73	50.07	55.02	-114.09	-14.23
Change in Inventory	-	-	-	-	-	-2.74
Change in Accounts Payable	52.86	4.77	-1.18	-10.84	-2.25	7.02
Change in Unearned Revenue	-28.08	-68.65	-35.92	-36.42	-10.5	-19.42
Change in Other Net Operating Assets	-44.83	-21.07	16.87	-44.77	65.3	2.85
Operating Cash Flow	-165.82	-319.59	-295.5	-252.2	-253.82	-135.83
Capital Expenditures	-21.37	-62.54	-40.8	-52.27	-56.52	-57.82
Sale of Property, Plant & Equipment	0.06	0.65	4.43	-	-	-
Cash Acquisitions	-	-5.4	-	74.73	-12.04	-
Divestitures	-	-	-42.98	-55.72	-	-
Investment in Securities	-327.67	4.52	-	-3.69	-5	-
Other Investing Activities	0.51	0.54	-1.34	-30.44	0.3	-
Investing Cash Flow	-348.47	-62.24	-80.69	-67.39	-73.26	-67.12
Long-Term Debt Repaid	-	-0.9	-1.3	-1.24	-1.12	-0.75
Net Debt Issued (Repaid)	-0.53	-0.9	-1.3	-1.24	-1.12	-0.75
Issuance of Common Stock	10.32	0.08	0.09	99.54	2,485	0.03
Repurchase of Common Stock	-	-	-0.02	-0.98	-901.71	-
Other Financing Activities	-0.36	-0.93	-1.99	-1.99	-48.19	-
Financing Cash Flow	9.43	-1.74	-3.22	95.34	1,534	90.32
Foreign Exchange Rate Adjustments	0.28	-0.28	-0.59	0.91	-0.02	-
Net Cash Flow	-504.58	-383.84	-380	-223.35	1,207	-112.63
Free Cash Flow	-187.19	-382.13	-336.3	-304.47	-310.34	-193.65
Free Cash Flow Margin	-103.64%	-168.31%	-133.74%	-63.74%	-98.89%	-252.62%
Free Cash Flow Per Share	-3.42	-7.36	-6.92	-7.25	-9.13	-6.08
Cash Interest Paid	0.03	0.03	0.08	0.09	2.37	2.57
Cash Income Tax Paid	0.89	0.89	0.67	-	0.06	-
Levered Free Cash Flow	-81.14	-235.06	-114.72	-1,325	444.82	-126.93
Unlevered Free Cash Flow	-81.08	-235	-114.67	-1,325	446.31	-125.44
Change in Working Capital	-18.32	-89.67	29.84	-37.01	-61.54	-26.52

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q